Repligen Co. (NASDAQ:RGEN - Free Report) - Analysts at William Blair increased their FY2025 earnings...
Repligen Co. (NASDAQ:RGEN – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2...
QGEN vs. RGEN: Which Stock Is the Better Value Option?...
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor le...
Wolfe Research upgraded shares of Repligen from a "peer perform" rating to an "outperform" rating an...